• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耐碳青霉烯类肠杆菌科细菌定植与感染的流行病学及危险因素:日本一家机构的病例对照研究

The epidemiology and risk factor of carbapenem-resistant enterobacteriaceae colonization and infections: Case control study in a single institute in Japan.

作者信息

Asai Nobuhiro, Sakanashi Daisuke, Suematsu Hiroyuki, Kato Hideo, Hagihara Mao, Nishiyama Naoya, Koizumi Yusuke, Yamagishi Yuka, Mikamo Hiroshige

机构信息

Department of Clinical Infectious Diseases, Aichi Medical University Hospital, Aichi, Japan; Department of Infection Control and Prevention, Aichi Medical University Hospital, Aichi, Japan.

Department of Infection Control and Prevention, Aichi Medical University Hospital, Aichi, Japan.

出版信息

J Infect Chemother. 2018 Jul;24(7):505-509. doi: 10.1016/j.jiac.2018.02.005. Epub 2018 Mar 13.

DOI:10.1016/j.jiac.2018.02.005
PMID:29548627
Abstract

INTRODUCTION

While the emergence and spread of carbapenem-resistant enterobacteriaceae (CRE) carriage and infections are serious threats to public health worldwide, its prevalence and epidemiology are still unknown.

METHODS AND PATIENTS

For the purpose of examining the prevalence, patients' background and risk factors for CRE carriage and infections, we conducted this case-control study. We retrospectively reviewed all patients isolating CRE at Aichi Medical University hospital from January 2010 until March 2017. The patients isolated with carbapenem-susceptible enterobacteriaceae (CSE) were randomly selected during the study period.

RESULTS

A total of 26 patients, isolating 28 CRE infections were enrolled in this study. The detection rate of CRE carriage and infection was 0.22% (28/12,600). Compared to the CSE group, the CRE group had poorer PS and higher CCI scores. The CRE group tended to stay longer in hospital (121 v.s. 63 days, p = 0.052) and admission fee was much more expensive than CSE group (220,710 v.s. 69,904 JPY, p < 0.001). PS 2-4 (ECOG) and CCI≧3 (p = 0.002), prior hospitalization within 90 days (p = 0.006) and prior antibiotics use within 90 days (p = 0.005) were risk factors for acquisition of CRE by univariate analysis. The combination of PS 2-4 and CCI≧3 was an independent risk factor for CRE carriage and infection by multivariate logistic regression analysis.

CONCLUSION

The combination of PS 2-4 (ECOG) and CCI score≧3 was an independent risk factor of CRE carriage and infections. The CRE group tended to stay longer in hospital, and the medical expense was much more expensive than those in the CSE group.

摘要

引言

虽然耐碳青霉烯类肠杆菌科细菌(CRE)携带及感染的出现和传播对全球公共卫生构成严重威胁,但其流行情况和流行病学特征仍不明确。

方法与患者

为了研究CRE携带及感染的流行情况、患者背景和危险因素,我们开展了这项病例对照研究。我们回顾性分析了2010年1月至2017年3月在爱知医科大学医院分离出CRE的所有患者。在研究期间随机选取分离出碳青霉烯类敏感肠杆菌科细菌(CSE)的患者。

结果

本研究共纳入26例患者,分离出28例CRE感染。CRE携带及感染的检出率为0.22%(28/12,600)。与CSE组相比,CRE组的体能状态(PS)较差,合并症指数(CCI)得分较高。CRE组的住院时间往往更长(121天对63天,p = 0.052),入院费用比CSE组高得多(220,710日元对69,904日元,p < 0.001)。单因素分析显示,PS 2 - 4(东部肿瘤协作组)和CCI≥3(p = 0.002)、90天内曾住院(p = 0.006)以及90天内曾使用抗生素(p = 0.005)是获得CRE的危险因素。多因素逻辑回归分析显示,PS 2 - 4和CCI≥3的组合是CRE携带及感染的独立危险因素。

结论

PS 2 - 4(东部肿瘤协作组)和CCI得分≥3的组合是CRE携带及感染的独立危险因素。CRE组的住院时间往往更长,医疗费用比CSE组高得多。

相似文献

1
The epidemiology and risk factor of carbapenem-resistant enterobacteriaceae colonization and infections: Case control study in a single institute in Japan.耐碳青霉烯类肠杆菌科细菌定植与感染的流行病学及危险因素:日本一家机构的病例对照研究
J Infect Chemother. 2018 Jul;24(7):505-509. doi: 10.1016/j.jiac.2018.02.005. Epub 2018 Mar 13.
2
Fecal carriage of carbapenem-resistant Enterobacteriaceae in a Chinese university hospital.中国某大学医院中耐碳青霉烯类肠杆菌科细菌的粪便携带情况。
Am J Infect Control. 2014 May;42(5):e61-4. doi: 10.1016/j.ajic.2014.01.024.
3
Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers.重症患者中耐碳青霉烯类肠杆菌科细菌的定植与感染:与非携带者的回顾性匹配队列比较
J Hosp Infect. 2016 Sep;94(1):54-9. doi: 10.1016/j.jhin.2016.05.018. Epub 2016 Jun 6.
4
Prevalence of, and risk factors for, carriage of carbapenem-resistant Enterobacteriaceae among hospitalized patients in Japan.日本住院患者中产碳青霉烯类耐药肠杆菌科的流行情况及危险因素。
J Hosp Infect. 2017 Nov;97(3):212-217. doi: 10.1016/j.jhin.2017.07.015. Epub 2017 Jul 20.
5
Epidemiology and risk factors for carbapenem-resistant Enterobacteriaceae colonisation and infections: case-controlled study from an academic medical center in a southern area of China.中国南方某学术医学中心的一项肠杆菌科碳青霉烯耐药定植和感染的流行病学和危险因素:病例对照研究。
Pathog Dis. 2019 Jun 1;77(4). doi: 10.1093/femspd/ftz034.
6
Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children.儿童耐碳青霉烯肠杆菌科定植或感染的危险因素的多中心研究。
Antimicrob Agents Chemother. 2017 Nov 22;61(12). doi: 10.1128/AAC.01440-17. Print 2017 Dec.
7
Risk factors for fecal carriage of IMP-6-producing Enterobacteriaceae at a long-term care hospital in Japan: A follow-up report from the northern Osaka multicentre study group.日本一家长期护理医院产 IMP-6 肠杆菌科细菌粪便携带的危险因素:大阪北部多中心研究组的随访报告
J Infect Chemother. 2018 Sep;24(9):769-772. doi: 10.1016/j.jiac.2018.03.009. Epub 2018 Apr 12.
8
Screening of nursing home residents for colonization with carbapenem-resistant Enterobacteriaceae admitted to acute care hospitals: Incidence and risk factors.对入住急症医院的养老院居民进行耐碳青霉烯类肠杆菌科细菌定植筛查:发病率及危险因素
Am J Infect Control. 2016 Feb;44(2):126-30. doi: 10.1016/j.ajic.2015.09.019. Epub 2015 Nov 26.
9
Predictors of Persistent Carbapenem-Resistant Enterobacteriaceae Carriage upon Readmission and Score Development.再次入院时耐碳青霉烯类肠杆菌科细菌持续携带的预测因素及评分系统的开发
Infect Control Hosp Epidemiol. 2016 Feb;37(2):188-96. doi: 10.1017/ice.2015.278. Epub 2016 Jan 11.
10
Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections.耐碳青霉烯类肠杆菌科细菌医院感染的危险因素及临床结局
Eur J Clin Microbiol Infect Dis. 2016 Oct;35(10):1679-89. doi: 10.1007/s10096-016-2710-0. Epub 2016 Jul 11.

引用本文的文献

1
Risk factors for Carbapenem-resistant Enterobacterales infections: A case-control study.耐碳青霉烯类肠杆菌科细菌感染的危险因素:一项病例对照研究。
S Afr Fam Pract (2004). 2025 Feb 7;67(1):e1-e10. doi: 10.4102/safp.v67i1.6029.
2
[Real-time rectal swab Xpert Carba-R assay for early warning of CRO bloodstream infection in patients undergoing hematopoietic stem cell transplant: a clinical feasibility study].[实时直肠拭子Xpert Carba-R检测用于造血干细胞移植患者碳青霉烯类耐药菌血流感染的早期预警:一项临床可行性研究]
Zhonghua Xue Ye Xue Za Zhi. 2024 Nov 14;45(11):1043-1050. doi: 10.3760/cma.j.cn121090-20240607-00213.
3
Predictors of Mortality, Drug Resistance, and Determinants among Carbapenem-Resistant Infections in Chinese Elderly Patients.
中国老年患者碳青霉烯类耐药感染的死亡率、耐药性及决定因素的预测指标
Can J Infect Dis Med Microbiol. 2024 Aug 28;2024:5459549. doi: 10.1155/2024/5459549. eCollection 2024.
4
Burden of Antimicrobial Resistance in Japan: A Systematic Literature Review and Meta-Analysis.日本抗菌药物耐药性负担:系统文献综述与荟萃分析
Infect Dis Ther. 2024 May;13(5):1105-1125. doi: 10.1007/s40121-024-00960-z. Epub 2024 Apr 25.
5
Antimicrobial Use and Carbapenem-Resistant Enterobacterales in Korea: A Nationwide Case-Control Study With Propensity Score Matching.韩国的抗菌药物使用与碳青霉烯类耐药肠杆菌科细菌:一项全国范围内的病例对照研究与倾向评分匹配。
J Korean Med Sci. 2024 Apr 15;39(14):e132. doi: 10.3346/jkms.2024.39.e132.
6
An observational study on carbapenem-resistant Enterobacterales (CRE) colonisation and subsequent risk of infection in an adult intensive care unit (ICU) at a tertiary care hospital in India.印度一家三级护理医院成人重症监护病房(ICU)中耐碳青霉烯类肠杆菌科细菌(CRE)定植及后续感染风险的观察性研究。
Infect Prev Pract. 2023 Sep 30;5(4):100312. doi: 10.1016/j.infpip.2023.100312. eCollection 2023 Dec.
7
Updates on the Status of Carbapenem-Resistant Enterobacterales in Lebanon.黎巴嫩耐碳青霉烯类肠杆菌科细菌现状的最新情况
Int J Microbiol. 2023 May 29;2023:8831804. doi: 10.1155/2023/8831804. eCollection 2023.
8
Biochemical exploration of β-lactamase inhibitors.β-内酰胺酶抑制剂的生化探索
Front Genet. 2023 Jan 17;13:1060736. doi: 10.3389/fgene.2022.1060736. eCollection 2022.
9
Treatments and Predictors of Mortality for Carbapenem-Resistant Gram-Negative Bacilli Infections in Malaysia: A Retrospective Cohort Study.马来西亚耐碳青霉烯类革兰氏阴性杆菌感染的治疗方法及死亡率预测因素:一项回顾性队列研究
Trop Med Infect Dis. 2022 Dec 2;7(12):415. doi: 10.3390/tropicalmed7120415.
10
High frequency of carbapenem-resistant Enterobacteriaceae fecal carriage among ICU hospitalized patients from Southern Iran.伊朗南部重症监护病房住院患者中耐碳青霉烯类肠杆菌科细菌粪便携带率高。
Iran J Basic Med Sci. 2022 Dec;25(12):1416-1423. doi: 10.22038/IJBMS.2022.63099.13938.